Return to Headlines
Prana Biotechnology is Among the Companies With the Highest Upside Potential in the Biotechnology Industry (PRAN, PYMX, OXGN, AVII, CYTK)
Written on Wed, 04/14/2010 - 01:25
By Chip Brian
Below are the top five companies in the Biotechnology industry as measured by the potential gains between the current stock price and the projected average analyst target.
Prana Biotechnology (NASDAQ:PRAN) has a potential upside of 493% based on a current price of $1.35 and an average consensus analyst price target of $8.
PolyMedix (NASDAQ:PYMX) has a potential upside of 313% based on a current price of $1.15 and an average consensus analyst price target of $4.75.
OXiGENE (NASDAQ:OXGN) has a potential upside of 220% based on a current price of $1.25 and an average consensus analyst price target of $4.
AVI BioPharma (NASDAQ:AVII) has a potential upside of 204.9% based on a current price of $1.23 and an average consensus analyst price target of $3.75.
Cytokinetics (NASDAQ:CYTK) has a potential upside of 193.8% based on a current price of $3.37 and an average consensus analyst price target of $9.9.
SmarTrend is bearish on shares of AVII and our subscribers were alerted to Sell on February 10, 2010 at $1.39. The stock has fallen 11.5% since the alert was issued.
Keywords: prana biotechnology upside potential
Ticker(s): PRAN PYMX OXGN AVII CYTK
http://www.TradeTheTrend.com/signup.html.
one opinion 493% upside
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(11.1%) |
Mkt cap ! $20.98M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $14.55K | 3.241M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 71906262 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 32338803 | 25 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |